1. Home
  2. KTTA vs PRHI Comparison

KTTA vs PRHI Comparison

Compare KTTA & PRHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

SELL

Current Price

$0.48

Market Cap

15.6M

Sector

Health Care

ML Signal

SELL

PRHI

Presurance Holdings Inc.

HOLD

Current Price

$4.08

Market Cap

18.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
PRHI
Founded
2020
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
18.7M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
KTTA
PRHI
Price
$0.48
$4.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.4M
24.4K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.07
N/A
EPS
N/A
★ 1.06
Revenue
$486,559.00
★ $43,304,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$4.01
Revenue Growth
★ 3130.37
N/A
52 Week Low
$0.32
$0.59
52 Week High
$2.06
$9.63

Technical Indicators

Market Signals
Indicator
KTTA
PRHI
Relative Strength Index (RSI) 49.53 24.64
Support Level $0.42 $0.59
Resistance Level $0.57 $5.92
Average True Range (ATR) 0.08 0.68
MACD -0.00 -0.31
Stochastic Oscillator 48.59 7.40

Price Performance

Historical Comparison
KTTA
PRHI

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About PRHI Presurance Holdings Inc.

Presurance Holdings Inc is an insurance holding company that markets and services product offerings through specialty personal insurance lines of business. Through its personal insurance lines, it offers homeowners insurance and dwelling fire insurance products to individuals in several states. The specialty homeowners insurance product line is comprised of low-value dwelling insurance tailored for owners of lower valued homes, which it offers in Texas, Illinois and Indiana. Through commercial insurance lines, it offers coverage for both commercial property and commercial liability and also offered coverage for commercial automobiles and workers' compensation. Its revenues are derived from premiums earned from insurance operations.

Share on Social Networks: